鱼跃医疗：12月24日召开董事会会议

Core Viewpoint - Yuyue Medical (SZ 002223) announced a temporary board meeting on December 24, 2025, to discuss the feasibility report on foreign exchange hedging business [1] Group 1: Company Financials - For the first half of 2025, Yuyue Medical's revenue composition is as follows: respiratory therapy solutions accounted for 35.93%, clinical instruments and rehabilitation solutions for 24.35%, home health testing solutions for 21.77%, blood glucose management and POCT solutions for 14.48%, and emergency solutions and others for 2.92% [1] - As of the report, Yuyue Medical's market capitalization is 36.9 billion yuan [1]